Novel Oral Drug Combo Fast Tracked for Obstructive Sleep Apnea
The designation is supported by data from the phase 2 MARIPOSA study, which included adults with mild to moderate OSA.
The designation is supported by data from the phase 2 MARIPOSA study, which included adults with mild to moderate OSA.
Findings seen in secondary analysis of data for children randomly assigned to adenotonsillectomy or watchful waiting for nonsevere OSA
Meta-analysis shows sleep apnea linked to increased risk for sudden death, cardiovascular mortality
Screening for obstructive sleep apnea recommended for those with resistant/poorly controlled HTN, pulmonary HTN, recurrent a-fib
The eXciteOSA device is used while the individual is awake and provides electrical muscle stimulation through a mouthpiece that sits around the tongue.
Patients with sleep apnea who received positive airway pressure therapy did not exhibit reduced cardiovascular risk compared with patients who received usual care.
Researchers examined patients with central sleep apnea after 5 years of treatment with transvenous phrenic nerve stimulation therapy.
The list, titled “Five Things Physicians and Patients Should Question,” was developed by members of the AAP Section on Pediatric Pulmonology and Sleep Medicine.
Continuous positive airway pressure therapy for 6 months offers patients with obstructive sleep apnea a greater chance of reversing metabolic syndrome.
In terms of screening for obstructive sleep apnea in people living with HIV, the STOP-BANG questionnaire had good sensitivity, whereas the Berlin questionnaire and the Epworth Sleepiness Scale demonstrated good specificity.